Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or ...

The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Health insurance companies, including CVS Caremark, are altering coverage for GLP-1 weight loss medications like Zepbound, ...

Weight-loss jabs will be made available to the poorest who have the highest need, the Government has said in the NHS 10-year ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.

A report from the human resources trade group SHRM, which just released its 2025 Benefits Survey—the most comprehensive ...

As demand for obesity drugs rises, questions emerge over approvals granted without India-specific safety and efficacy trials.